Cancer Family
Urinary System Neoplasm
CI-CAN-00000379Explore in graph →
Non-malignant964 active trials28 approved drugs109 evidence items
- NCIt
- C3431
Loading cancer entity…
Cancer Family
CI-CAN-00000379Explore in graph →
Clinical trials
4,238 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04567719 | Measuring Taste Perception During Chemotherapy for Muscle Invasive Bladder Cancer | unknown | — | 9 | University of Kansas Medical CenterOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT05297552 | A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer | unknown | Phase 2 | 40 | RemeGen Co., Ltd.INDUSTRY | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06253091 | Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy | unknown | N/A | 50 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT03924466 | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients(VUBAR) | unknown | Phase 2 | 55 | Universitair Ziekenhuis BrusselOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06148220 | A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors | unknown | N/A | 20 | Huashan HospitalOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT05829057 | The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 | unknown | Phase 1 | 10 | Zhejiang UniversityOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT04149691 | Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies | unknown | Phase 1 | 42 | Celon Pharma SAINDUSTRY | 1 | Feb 7, 2024 | clinicaltrials |
| NCT06245759 | The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients | unknown | — | 120,000 | Huazhong University of Science and TechnologyOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT06235268 | Prospective and Multicenter Italian Registry of Locally Advanced-Metastatic Urothelial Carcinoma | unknown | — | 1,000 | Federation of Italian Cooperative Oncology GroupsOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT05193656 | Bladder Cancer Detection Using Convolutional Neural Networks(BLAInostic) | unknown | — | 5,000 | Zealand University HospitalOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT06221774 | Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors | unknown | Phase 1 / Phase 2 | 42 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT06222125 | A Study of HB0025 Injection in Patients With Advanced Renal Cancer | unknown | Phase 2 | 100 | Huabo Biopharm Co., Ltd.INDUSTRY | 1 | Jan 24, 2024 | clinicaltrials |
| NCT06182644 | Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors(FAPI) | unknown | N/A | 30 | Guangdong Provincial People's HospitalOTHER | 1 | Jan 22, 2024 | clinicaltrials |
| NCT04994197 | Urothelial Tumor Risk Genes Detection With Genetron Uro V1 and LC-WGS | unknown | — | 970 | Ruijin HospitalOTHER | 1 | Jan 10, 2024 | clinicaltrials |
| NCT06182735 | CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell Carcinoma | unknown | Phase 1 | 9 | Fudan UniversityOTHER | 1 | Dec 27, 2023 | clinicaltrials |
| NCT06178601 | A Study of RC48-ADC Combined With Cadonilimab(AK104)in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma | unknown | Phase 2 | 36 | Shanxi Province Cancer HospitalOTHER | 1 | Dec 21, 2023 | clinicaltrials |
| NCT02969083 | Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma(URANUS) | unknown | Phase 2 | 200 | The European Uro-Oncology GroupOTHER | 3 | Dec 18, 2023 | clinicaltrials |
| NCT03108703 | Assessment of QoL and Outcomes With SBRT for RCC(AQuOS-RCC) | unknown | N/A | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 7, 2023 | clinicaltrials |
| NCT06152666 | Day-case Endourology; Enablers, Barriers, Unexpected Outcomes | unknown | — | 15 | Royal Devon and Exeter NHS Foundation TrustOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT06152679 | Day-case Endourology; Patient Experience | unknown | — | 15 | Royal Devon and Exeter NHS Foundation TrustOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT06153849 | Analyzing the Urine During BCG Instillation in Bladder Cancer Patients for Disease Followup | unknown | — | 100 | Changhai HospitalOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT05949424 | OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults(OPTI-DOSE) | unknown | Phase 4 | 30 | University Medical Center GroningenOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT04040530 | Patient Reported Outcome After Nephron Sparing Treatment of Small Renal Tumours | unknown | — | 187 | Region of Southern DenmarkOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06134700 | Low Pressure Versus Standard Pressure Pneumoperitoneum in Laparoscopic Nephrectomy | unknown | N/A | 44 | Institute of medicine, Maharagjung medical campusOTHER | 0 | Nov 18, 2023 | clinicaltrials |
| NCT06129955 | Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma | unknown | Phase 2 | 47 | Sun Yat-sen UniversityOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT06120413 | 18F-LN1 PET/CT in Urothelial Carcinomas | unknown | — | 30 | Sichuan Provincial People's HospitalOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT06115434 | Comparing Operative, Postoperative and Quality of Life of Patients After Salvage and Radical Cystectomy | unknown | — | 80 | Assiut UniversityOTHER | 1 | Nov 3, 2023 | clinicaltrials |
| NCT06113367 | Immunotherapy in Upper Tract Urothelial Carcinoma(VESUVIO) | unknown | — | 350 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Nov 2, 2023 | clinicaltrials |
| NCT04155359 | Clinical Evaluation of the miR Sentinel BCa™ Test to Diagnose Bladder Cancer in Hematuria Patients | unknown | — | 444 | miR Scientific LLCINDUSTRY | 1 | Oct 25, 2023 | clinicaltrials |
| NCT05259319 | Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)(IMMUNOs-SBRT) | unknown | Phase 1 | 92 | Centre Georges Francois LeclercOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT05176145 | Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test(DMIA) | unknown | N/A | 400 | VitadxOTHER | 3 | Oct 13, 2023 | clinicaltrials |
| NCT06074484 | A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer | unknown | Phase 2 | 36 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT05220189 | PENK Methylation Test for Detecting Bladder Cancer | unknown | — | 1,549 | Asan Medical CenterOTHER | 1 | Oct 4, 2023 | clinicaltrials |
| NCT06049030 | A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma | unknown | Phase 1 | 190 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 0 | Sep 26, 2023 | clinicaltrials |
| NCT05975151 | Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer | unknown | Phase 2 | 63 | Qilu Hospital of Shandong UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06046469 | Validity of Computed Tomography Versus Magnetic Resonance Imaging in Predicting Muscular Invasion of Bladder Cancer | unknown | N/A | 55 | Menoufia UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06033040 | Medical Imaging in Bladder Tumors by MRI | unknown | — | 178 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT06034015 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers | unknown | Phase 1 | 48 | Jiangsu Yahong Meditech Co., Ltd aka AsierisINDUSTRY | 1 | Sep 13, 2023 | clinicaltrials |
| NCT05534854 | Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes | unknown | — | 500 | RenJi HospitalOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT06009848 | Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer | unknown | Phase 2 | 20 | Tianjin Medical University Second HospitalOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT06005116 | [68Ga] NOTA-SGC8 in the Staging of Bladder Cancer | unknown | N/A | 64 | RenJi HospitalOTHER | 1 | Aug 22, 2023 | clinicaltrials |
| NCT05420519 | Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer | unknown | Phase 1 | 24 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05420545 | A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors | unknown | Phase 1 | 36 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05468190 | A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T | unknown | Phase 1 | 48 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Aug 18, 2023 | clinicaltrials |
| NCT03961698 | Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma(MARIO-3) | unknown | Phase 2 | 91 | Infinity Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05824299 | Influence of Anesthesia Methods on CTCs in TURBT Patients | unknown | N/A | 162 | RenJi HospitalOTHER | 1 | Aug 9, 2023 | clinicaltrials |
| NCT05462392 | Robot-assisted Urological Surgeries Using the MicroHand S Robot | unknown | N/A | 136 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Aug 2, 2023 | clinicaltrials |
| NCT05961111 | A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05879471 | 68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma | unknown | Phase 2 | 39 | Peking Union Medical College HospitalOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05739812 | The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery | unknown | N/A | 100 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Jul 14, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Feb 23, 2024source: clinicaltrials